Selzentry 300 MG Oral Tablet

RxCUI: 729203
RxNorm name: Selzentry 300 MG Oral Tablet
Display name: Selzentry 300 MG Oral Tablet
Full name: Selzentry 300 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SELZENTRY	MARAVIROC	ViiV Healthcare Company	46f30ac5-c96b-429e-976d-8c5ee1c0761b	2022-09-26	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 729203

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
46f30ac5-c96b-429e-976d-8c5ee1c0761b	Selzentry 300 MG Oral Tablet [PSN] · maraviroc 300 MG Oral Tablet [Selzentry] [SBD] · Selzentry 300 MG Oral Tablet [SY]	3	25	These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) tablets, for oral use SELZENTRY (maraviroc) oral solution Initial U.S. Approval: 2007	20220926
2b5e5c5d-852a-413b-825c-8491d4539e67	Selzentry 300 MG Oral Tablet [PSN] · maraviroc 300 MG Oral Tablet [Selzentry] [SBD] · Selzentry 300 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use SELZENTRY safely and effectively. See full prescribing information for SELZENTRY. SELZENTRY (maraviroc) Tablets Initial U.S. Approval: 2007	20120523